Cargando…

Nonalcoholic fatty liver disease and risk of incident hypertension: a systematic review and meta-analysis

Several studies reported an association between nonalcoholic fatty liver disease (NAFLD) and the risk of incident hypertension. The objective of this systematic review and meta-analysis was to obtain a precise and reliable estimate of the nature and magnitude of this association. We systematically s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciardullo, Stefano, Grassi, Guido, Mancia, Giuseppe, Perseghin, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876398/ https://www.ncbi.nlm.nih.gov/pubmed/34678858 http://dx.doi.org/10.1097/MEG.0000000000002299

Ejemplares similares

Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition
por: Ciardullo, Stefano, et al.
Publicado: (2023)

Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Lack of awareness of liver organ damage in patients with type 2 diabetes
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients
por: Rea, Federico, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
por: Bonapace, Stefano, et al.
Publicado: (2012)

Soluble α-Klotho levels, glycemic control and renal function in US adults with type 2 diabetes
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States
por: Ciardullo, Stefano, et al.
Publicado: (2022)

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications
por: Ciardullo, Stefano, et al.
Publicado: (2020)

Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis
por: Perseghin, Gianluca
Publicado: (2011)

Insomnia and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis
por: Wijarnpreecha, K, et al.
Publicado: (2017)

Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement
por: Grassi, Guido, et al.
Publicado: (2021)

Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study
por: Ciardullo, Stefano, et al.
Publicado: (2022)

White-Coat Hypertension: the Neglected Subgroup in Hypertension
por: Cuspidi, Cesare, et al.
Publicado: (2018)

Global incidence and prevalence of nonalcoholic fatty liver disease
por: Teng, Margaret LP, et al.
Publicado: (2023)

Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
por: Xiao, Meng-Wei, et al.
Publicado: (2019)

Hypertension and COVID-19: Ongoing Controversies
por: Tadic, Marijana, et al.
Publicado: (2021)

COVID‐19 and arterial hypertension: Hypothesis or evidence?
por: Tadic, Marijana, et al.
Publicado: (2020)

Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2018)

Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms
por: Mitten, Emilie K., et al.
Publicado: (2023)

Short sleep duration and the risk of nonalcoholic fatty liver disease/metabolic associated fatty liver disease: a systematic review and meta-analysis
por: Yang, Jie, et al.
Publicado: (2022)

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Tang, Yao, et al.
Publicado: (2019)

Epidemiology of nonalcoholic fatty liver disease in Europe: a systematic review and meta-analysis
por: Cholongitas, Evangelos, et al.
Publicado: (2021)

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

White-Coat Hypertension: Pathophysiological and Clinical Aspects: Excellence Award for Hypertension Research 2020
por: Mancia, Giuseppe, et al.
Publicado: (2021)

Incidence of Metabolic Syndrome and Its Risk Factors in Elderly with Nonalcoholic Fatty Liver Disease
por: Lin, Fang-An, et al.
Publicado: (2023)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
por: Ismaiel, Abdulrahman, et al.
Publicado: (2021)

Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023)

Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses
por: Zhong, Lixian, et al.
Publicado: (2022)

Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study
por: Grassi, Guido, et al.
Publicado: (2022)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
por: Golubeva, Julia A., et al.
Publicado: (2023)

Incidence of nonalcoholic fatty liver disease in patients undergoing laparoscopic cholecystectomy
por: Hajong, Ranendra, et al.
Publicado: (2018)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Outcome of Phlebotomy for Treating Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
por: Jaruvongvanich, Veeravich, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: A systematic review and meta‐analysis
por: Zhou, Yao‐Yao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_96t7at0m7lsdvn5h5megv7v273